US Patent 6908934 Therapeutic compounds for treating dyslipidemic conditions
Patent 6908934 was granted and assigned to Merck & Co., Inc. on June, 2005 by the United States Patent and Trademark Office.
All edits
Edits on 6 Nov, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 Oct, 2023
Golden AI
Edits made to:
Infobox (+18 properties)
Article (+313 characters)
Article
Patent abstract
Compounds of Formula Iand the pharmaceutically acceptable salts and esters thereof, wherein Z is selected from the group consisting of:(a) Formula Ia and(b) Formula Ibare novel LXR agonists and are useful in the treatment of dyslipidemic conditions particularly depressed levels of HDL cholesterol.
Infobox
Is a
Patent Applicant
0
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
A. Brian Jones0
Aileen Bouffard0
Alan D. Adams0
Ali Shiafee0
Clare E. Gutteridge0
James F. Dropinski0
John George Ondeyka0
Sheo Bux Singh0
Weiguo Lui0
Date of Patent
June 21, 2005
0Patent Application Number
101586790
Date Filed
May 30, 2002
0Patent Primary Examiner
Golden AI
Edits made to:
US Patent 6908934 Therapeutic compounds for treating dyslipidemic conditions
Find more entities like US Patent 6908934 Therapeutic compounds for treating dyslipidemic conditions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
